Clinical trial
Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors
NCT00003241 · Texas Children's Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003241 |
|---|---|
| Title | Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors |
| Official title | Phase II Study of Phenylacetate in Pediatric Patients With Central Nervous System Tumors |
| Lead sponsor | Texas Children's Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | phenylacetate |
| Start date | May 1, 1998 |
| Completion | Sep 1, 2004 |
| First posted | Sep 10, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: